POLYNEUROPATHY, INFLAMMATORY DEMYELINATING, CHRONIC

Clinical trials for POLYNEUROPATHY, INFLAMMATORY DEMYELINATING, CHRONIC explained in plain language.

Never miss a new study

Get alerted when new POLYNEUROPATHY, INFLAMMATORY DEMYELINATING, CHRONIC trials appear

Sign up with your email to follow new studies for POLYNEUROPATHY, INFLAMMATORY DEMYELINATING, CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New drug trial offers hope for patients with Hard-to-Treat nerve disease

Disease control Recruiting now

This study is testing whether an investigational drug called riliprubart can help adults with a chronic nerve disorder called CIDP when standard treatments like steroids or immunoglobulins have not worked well enough. Participants will receive either riliprubart or a placebo (ina…

Matched conditions: POLYNEUROPATHY, INFLAMMATORY DEMYELINATING, CHRONIC

Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

POLYNEUROPATHY, INFLAMMATORY DEMYELINATING, CHRONIC

Get alerted when new POLYNEUROPATHY, INFLAMMATORY DEMYELINATING, CHRONIC trials appear

New drug trial offers hope for patients with Hard-to-Treat nerve disease